A Study to Assess the Effect of S-600918 on the Pharmacokinetics of Fexofenadine, Rosuvastatin, and Atorvastatin in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Healthy subjects
- Registration Number
- JPRN-jRCT2080224683
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Male
- Target Recruitment
- 42
Inclusion Criteria
Healthy male subjects
Exclusion Criteria
Subjects who are considered ineligible for this study by the investigator or subinvestigator due to current or history of significant metabolic or endocrine, hepatic, renal, hematological, pulmonary, cardiovascular, gastrointestinal, urological, immune, neurological or psychiatric disorders, or other clinically significant diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method